38 results
Page of 4
  • ACCL1333

    A study designed to evaluate the safety and efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in children with newly diagnosed Acute Lympho.

    Type: Treatment

    Principal Investigator: Richard Drachtman, MD

    Trial is open for enrollment

    For inquiries, call (732) 235-8861
    • Rutgers Robert Wood Johnson Medical School
    • Robert Wood Johnson University Hospital
  • ACURATE

    Evaluation of the safety and efficacy of the Acurate valve for transcatheter aortic valve replacement (TAVR)

    Type: Device trial

    Principal Investigator: Mark Russo, MD

    Trial is open for enrollment

    For inquiries, call (732) 235-9215

    • Rutgers Robert Wood Johnson Medical School
    • Robert Wood Johnson University Hospital
  • AEGIS II

    A phase 3, multi-center, double-blind, randomized, placebo-controlled, parallel-group study designed to investigate the efficacy and safety of CSL 112 (Apolipoprotein A-I: human) on reducing the risk of major adverse CV events in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI), including those managed with percutaneous coronary intervention (PCI) or medically managed.

    Type: Treatment

    Trial is open for enrollment

    View All Details
    • Principal Investigator:
      Sharan Mahal, MD

    For inquiries, call (908) 864-4027
    • RWJ University Hospital Somerset
  • ALIGN-AR

    To evaluate the safety and effectiveness/performance of the Transfemoral JenaValve Pericardial TAVR System in the treatment of patients with symptomatic severe aortic regurgitation.

    Type: Device trial

    Principal Investigator: Mark Russo, MD

    Trial is open for enrollment

    For inquiries, call (732) 235-9215

    • Rutgers Robert Wood Johnson Medical School
    • Robert Wood Johnson University Hospital
  • ALIGN-AS

    To evaluate the safety and effectiveness/performance of the Transfemoral JenaValve Pericardial TAVR System in the treatment of patients with symptomatic severe aortic stenosis.

    Type: Device trial

    Principal Investigator: Mark Russo, MD

    Trial is open for enrollment

    For inquiries, call (732) 235-9215

    • Rutgers Robert Wood Johnson Medical School
    • Robert Wood Johnson University Hospital
  • AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial

    A study designed to evaluate the safety and effectiveness of the AMPLATZER Amulet Left Atrial Appendage Occluder.

    Trial is open for enrollment

    View All Details
    • Principal Investigator:
      Dobesh, David M.D.

    For inquiries, call (973) 736-6333
    • Cooperman Barnabas Medical Center
  • ARRAY 797-301

    A phase 3, multinational, randomized, placebo-controlled study of ARRY-371797 in patients with symptomatic dilated cardiomyopathy due to a lamin A/C gene mutation.

    Type: Drug trial

    Principal Investigator: Saurabh Kapoor, MD

    Trial is open for enrollment

    For inquiries, call (973) 926-8451
    • Newark Beth Israel Medical Center
  • Assessing the Normal Microbiome and Virome of the Lung: A Pilot Study

    Trial is open for enrollment.

    View All Details
    • Principal Investigator:
      Subroto Paul M.D.

    For inquiries, call (973) 322-2224
    • Cooperman Barnabas Medical Center
  • Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

    Trial is open for enrollment.

    View All Details
    • Principal Investigator:
      Dobesh, David M.D.

    For inquiries, call (973) 736-6333
    • Cooperman Barnabas Medical Center
  • BiSpectral Index (BIS) Monitoring and Sedation Practices in Critically Ill Mechanically Ventilated Patients: A Single Center, Prospective, Randomized Control Trial

    Trial is open for enrollment

    View All Details
    • Principal Investigator:
      Nirav Mistry M.D.

    For inquiries, call (973) 322-2224
    • Cooperman Barnabas Medical Center
  • CIRT

    A randomized clinical trial investigating whether taking low-dose methotrexate reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages.

    Type: Drug trial

    Principal Investigator: John B. Kostis, MD

    Trial is open for enrollment

    For inquiries, call (732) 235-6546
    • Rutgers Robert Wood Johnson Medical School
    • Robert Wood Johnson University Hospital
  • CLASP II TR

    A study designed to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation.

    Principal Investigator: Mark Russo, MD

    Type: Device

    This trial is open for enrollment

    For inquiries, call (732) 235-9215
    • Robert Wood Johnson University Hospital
Page of 4